In a major regulatory move aimed at streamlining equity derivatives trading in India, the Securities and Exchange Board of India (SEBI) has approved a significant reshuffle of weekly expiry days across the country’s two biggest stock exchanges. Effective September 1, 2025, the National Stock Exchange (NSE) will transition its equity derivatives expiry to Tuesday, while the Bombay Stock Exchange (BSE) will switch to Thursday
SEBI’s directive stems from a circular issued in late May 2025, mandating that all equity derivative contracts—including weekly, monthly, and longer tenors—must expire only on Tuesdays or Thursdays. The primary goals are:
NSE gains tactical edge
With expiry now landing on Tuesday, traders on NSE benefit from an extra trading day—Friday, Monday, and Tuesday—to adjust or hedge positions. This “theta-play” window allows for strategic maneuvering ahead of expiration.
BSE navigates a tighter window
BSE’s new schedule offers just two sessions—Wednesday and Thursday—which may make it harder to attract traders. Analysts anticipate possible volume erosion of 10–15%, translating into a 5–10% hit to earnings.
To fortify liquidity, BSE plans to ramp up infrastructure—such as colocation racks—and onboard more brokers and foreign portfolio investors (FPIs).
SEBI’s expiry-day realignment represents a pivotal step toward greater structure and stability in India's derivatives market. By assigning discrete expiry days—Tuesday to NSE, Thursday to BSE—regulators aim to eliminate confusion, limit speculation, and bolster investor confidence.
For traders and market operators, this doesn’t just mean a calendar update—it’s a call to actively revisit strategies, plan for new timelines, and adapt to a market that’s becoming cleaner, smarter, and more regulated.
This article is for informational purposes only and does not constitute financial advice. It is not produced by the desk of the Kotak Securities Research Team, nor is it a report published by the Kotak Securities Research Team. The information presented is compiled from several secondary sources available on the internet and may change over time. Investors should conduct their own research and consult with financial professionals before making any investment decisions. Read the full disclaimer here.
Investments in securities market are subject to market risks, read all the related documents carefully before investing. Brokerage will not exceed SEBI prescribed limit. The securities are quoted as an example and not as a recommendation. SEBI Registration No-INZ000200137 Member Id NSE-08081; BSE-673; MSE-1024, MCX-56285, NCDEX-1262.